Strong association of a tumor necrosis factor-alpha promoter allele with cerebral malaria in Myanmar

Tissue Antigens
R UbaleeK Hirayama

Abstract

To investigate the host genetic factors affecting the clinical course of falciparum malaria, polymorphism of the tumor necrosis factor-alpha (TNF-alpha) promoter region was analyzed in patients with cerebral malaria. Two hundred and forty-three Myanmar patients with falciparum malaria at Mae Sot Malaria clinic and Mae Sot General Hospital located at the border between Thailand and Myanmar, were included in this study. Among the patients (128 from Karen, 115 from Burma), 200 were uncomplicated and 43 had cerebral malaria. The TNF-alpha 5'- flanking region showed biallelic polymorphic sites at -238, -308, -857, -863, -1031, and there were 7 alleles (TNFP-A, B, C, D, M1, M4, M7) found in the patients from Myanmar. We found that the TNFP-D allele was significantly associated with cerebral malaria in the populations from Karen (Pc<0.0001, OR=124.86) and Burma (Pc<0.0001, OR=34.50). TNFP-D showed no significant linkage disequilibrium with any alleles of HLA-B or HLA-DRB1, suggesting that TNFP-D was primarily associated with cerebral malaria in Myanmar.

References

Aug 1, 1992·Human Immunology·M YoshidaT Sasazuki
Jun 15, 1989·The New England Journal of Medicine·G E GrauP H Lambert
Jul 1, 1988·The American Journal of Tropical Medicine and Hygiene·M Aikawa
Jun 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C Y TsengY H Lin
Nov 1, 1996·The Journal of Infectious Diseases·M B van HensbroekB Greenwood
Oct 1, 1996·Immunology and Cell Biology·J A BarbaraA Lopez
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·A G WilsonG W Duff
Oct 9, 1999·The Journal of Infectious Diseases·H BrownT Taylor

❮ Previous
Next ❯

Citations

Dec 4, 2003·Biological Psychiatry·Ene-Choo TanRathi Mahendran
Sep 12, 2003·Trends in Immunology·Nicholas H Hunt, Georges E Grau
Mar 25, 2004·Nature Reviews. Immunology·Mary M Stevenson, Eleanor M Riley
Nov 5, 2002·Clinical and Diagnostic Laboratory Immunology·Iñigo Angulo, Manuel Fresno
Sep 19, 2006·American Journal of Respiratory Cell and Molecular Biology·Laura E FredenburghS Alex Mitsialis
Oct 13, 2006·Malaria Journal·Ian A ClarkWilliam B Cowden
Mar 27, 2012·PLoS Neglected Tropical Diseases·Florencia del PuertoKenji Hirayama
Jul 28, 2011·Scandinavian Journal of Immunology·T Qidwai, F Khan
Jan 15, 2013·Journal of Tropical Medicine·Vitor R R de MendonçaManoel Barral-Netto
Apr 1, 2014·The Tohoku Journal of Experimental Medicine·Kazuhiko Igarashi, Miki Watanabe-Matsui
Jun 29, 2011·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Elisabeth IsraelssonKlavs Berzins
May 4, 2010·Experimental Parasitology·Louise M Randall, Christian R Engwerda
Jan 2, 2003·The Korean Journal of Parasitology·Kenji Hirayama
Apr 6, 2012·PloS One·Mingli LiuJonathan K Stiles
Nov 28, 2007·Annual Review of Pathology·Kasturi HaldarTerrie E Taylor
Oct 7, 2016·Tropical Medicine and Health·Saw Thu WahPornlada Nuchnoi
Feb 20, 2004·Genes and Immunity·J-P BayleyC L Verweij
Oct 31, 2013·Physiological Genomics·Maria Hernandez-ValladaresFuad A Iraqi
May 24, 2017·Scientific Reports·Arinjay BanerjeeVikram Misra
Jun 25, 2020·BMC Infectious Diseases·Luana LeãoRafael Rodrigues Lima
Dec 22, 2016·Mediators of Inflammation·Adriana Antônia da Cruz FuriniRicardo Luiz Dantas Machado
Aug 17, 2019·Frontiers in Immunology·Carlos Penha-Gonçalves

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.